[{"address1": "2 Burlington Woods Drive", "address2": "Suite 100", "city": "Burlington", "state": "MA", "zip": "01803", "country": "United States", "phone": "781 552 4452", "website": "https://www.bonebiologics.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jeffrey  Frelick", "age": 58, "title": "CEO & President", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 325000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.03, "open": 1.04, "dayLow": 1.01, "dayHigh": 1.07, "regularMarketPreviousClose": 1.03, "regularMarketOpen": 1.04, "regularMarketDayLow": 1.01, "regularMarketDayHigh": 1.07, "beta": 0.819, "forwardPE": -0.5333333, "volume": 104841, "regularMarketVolume": 104841, "averageVolume": 191847, "averageVolume10days": 210280, "averageDailyVolume10Day": 210280, "bid": 0.7632, "ask": 1.3, "bidSize": 200, "askSize": 200, "marketCap": 2562071, "fiftyTwoWeekLow": 0.8, "fiftyTwoWeekHigh": 4.49, "fiftyDayAverage": 1.07194, "twoHundredDayAverage": 1.443675, "currency": "USD", "enterpriseValue": -1004350, "floatShares": 2410593, "sharesOutstanding": 2463530, "sharesShort": 155013, "sharesShortPriorMonth": 55086, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0629, "heldPercentInsiders": 0.02822, "heldPercentInstitutions": 0.02846, "shortRatio": 0.68, "shortPercentOfFloat": 0.0638, "impliedSharesOutstanding": 2528940, "bookValue": 1.809, "priceToBook": 0.57490325, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -7353094, "trailingEps": -1.46, "forwardEps": -2.19, "lastSplitFactor": "1:8", "lastSplitDate": 1703030400, "52WeekChange": -0.7358974, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BBLG", "underlyingSymbol": "BBLG", "shortName": "Bone Biologics Corp", "longName": "Bone Biologics Corporation", "firstTradeDateEpochUtc": 1634131800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "ef723e6d-c4c0-3645-8eff-e1206a869bb4", "messageBoardId": "finmb_99330767", "gmtOffSetMilliseconds": -18000000, "currentPrice": 1.04, "targetHighPrice": 16.75, "targetLowPrice": 16.75, "targetMeanPrice": 16.75, "targetMedianPrice": 16.75, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 3566426, "totalCashPerShare": 1.448, "quickRatio": 13.045, "currentRatio": 14.871, "returnOnAssets": -0.52867, "returnOnEquity": -1.09171, "freeCashflow": -3116407, "operatingCashflow": -4789453, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]